Anne M. Landau

<i>In vivo</i>imaging of neuromelanin in Parkinson’s disease using¹⁸F-AV-1451 PET

Allan K. Hansen, Karoline Knudsen, Thea P. Lillethorup et al. · Brain · 2016 · 130 citations · Full text

Pet-mri, Neurochemical Biomarkers, Tau Tangle Ligand +25

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD

Agnete Kirkeby, Jenny Nelander, Deirdre B. Hoban et al. · Cell stem cell · 2023 · 120 citations · Full text

Cell Therapy, Cell Replacement Therapy, Biomedical Engineering +24

Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson’s disease

Jenny-Ann Phan, Kathrine Stokholm, Justyna Zarȩba-Pasławska et al. · Scientific Reports · 2017 · 99 citations · Full text

[11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates

Laura Kuebler, Sabrina Buss, Andrei Leonov et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 89 citations · Full text

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats

Majken Borup Thomsen, Sara A. Ferreira, Anna C. Schacht et al. · Neurobiology of Disease · 2020 · 69 citations · Full text